Exercise Promotion for Breast Cancer Survivors
This study is testing new ways to help breast cancer survivors be more physically active. It compares two approaches: "Affect-based exercise prescription," which encourages you to choose exercise that feels good, and "Effort-based exercise prescription," which focuses on how challenging the exercise feels. The study wants to see if the "Affect-based exercise prescription" helps at least 50% of participants get 90 minutes or more of moderate-to-vigorous physical activity each week, and how satisfied participants are with each approach. You may be able to join if you are 18 or older, finished primary breast cancer treatment (surgery, chemo, radiation) within the last 5 years for Stage 0-III breast cancer, and currently get less than 60 minutes of moderate-to-vigorous physical activity per week. The study is currently unclear on its recruitment status and plans to enroll 85 participants.
- Study design
- This is a randomized study, meaning participants will be assigned by chance to one of the two exercise approaches. It plans to enroll 85 participants.
- What's involved
- You will attend initial meetings and a 1-month check-in. You will also use a smartphone or tablet app to complete surveys during assessment periods.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your physical activity will be measured at 2 weeks, 6 weeks, and 12 weeks after starting the program.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
A Randomized Two-Arm Proof of Concept Study Testing A Novel Approach to Exercise Promotion Based on Affect-regulation
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Courtney J Stevens, PhD · PRINCIPAL_INVESTIGATOR · Dartmouth-Hitcock Health
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Average Minutes of Daily Moderate-vigorous Physical Activity Measured Using the ActiGraph wGT3X-BT Accelerometer at 2 Weeks Follow-up2-weeks follow-up assessment.
The research grade ActiGraph wGT3X-BT model is a valid measure of physical activity intensity and duration among multiple populations, including breast cancer survivors. Minutes of moderate-vigorous physical activity will be collected from the ActiGraph wGT3X-BT every day for 10-days. Average minutes of moderate-vigorous physical activity completed per day of valid wear time will be calculated.
- Average Minutes of Daily Moderate-vigorous Physical Activity Measured Using the ActiGraph wGT3X-BT Accelerometer at 6 Weeks Follow-up6-weeks follow-up assessment.
The research grade ActiGraph wGT3X-BT model is a valid measure of physical activity intensity and duration among multiple populations, including breast cancer survivors. Minutes of moderate-vigorous physical activity will be collected from the ActiGraph wGT3X-BT every day for 10-days. Average minutes of moderate-vigorous physical activity completed per day of valid wear time will be calculated.
- Average Minutes of Daily Moderate-vigorous Physical Activity Measured Using the ActiGraph wGT3X-BT Accelerometer at 12 Weeks Follow-up12-weeks follow-up assessment.
The research grade ActiGraph wGT3X-BT model is a valid measure of physical activity intensity and duration among multiple populations, including breast cancer survivors. Minutes of moderate-vigorous physical activity will be collected from the ActiGraph wGT3X-BT every day for 10-days. Average minutes of moderate-vigorous physical activity completed per day of valid wear time will be calculated.